Barclays’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$778K Sell
55,988
-165,245
-75% -$2.27M ﹤0.01% 2903
2025
Q4
$3.05M Buy
221,233
+77,209
+54% +$1.82M ﹤0.01% 2624
2025
Q3
$3.52M Buy
144,024
+11,683
+9% +$285K ﹤0.01% 2459
2025
Q2
$3.06M Buy
132,341
+64,575
+95% +$1.7M ﹤0.01% 2525
2025
Q1
$1.83M Sell
67,766
-196,204
-74% -$7.4M ﹤0.01% 2694
2024
Q4
$14.1M Buy
263,970
+89,909
+52% +$4.76M 0.01% 1314
2024
Q3
$7.91M Buy
174,061
+144,883
+497% +$6.3M ﹤0.01% 1659
2024
Q2
$1.22M Buy
29,178
+13,678
+88% +$642K ﹤0.01% 2481
2024
Q1
$584K Sell
15,500
-32,222
-68% -$702K ﹤0.01% 3492
2023
Q4
$512K Buy
47,722
+29,800
+166% +$258K ﹤0.01% 3854
2023
Q3
$181K Buy
17,922
+12,443
+227% +$143K ﹤0.01% 3346
2023
Q2
$65K Sell
5,479
-3,425
-38% -$45.8K ﹤0.01% 3724
2023
Q1
$108K Buy
8,904
+4,296
+93% +$71.5K ﹤0.01% 4135
2022
Q4
$60.7K Buy
4,608
+3,880
+533% +$56.8K ﹤0.01% 4471
2022
Q3
$10K Sell
728
-132
-15% -$1.76K ﹤0.01% 4301
2022
Q2
$11K Sell
860
-2,088
-71% -$24.7K ﹤0.01% 4599
2022
Q1
$42K Buy
+2,948
New +$48.2K ﹤0.01% 4180

Other funds holding JANX